Filing Details
- Accession Number:
- 0001181431-11-010705
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-16 14:41:14
- Reporting Period:
- 2011-02-14
- Filing Date:
- 2011-02-16
- Accepted Time:
- 2011-02-16 14:41:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024511 | J Michael Jandernoa | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-14 | 25,400 | $73.75 | 1,106,999 | No | 4 | S | Indirect | see footnote |
| Common Stock | Disposition | 2011-02-14 | 4,600 | $74.39 | 1,102,399 | No | 4 | S | Indirect | see footnote |
| Common Stock | Disposition | 2011-02-15 | 33,184 | $73.67 | 1,069,215 | No | 4 | S | Indirect | see footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | see footnote |
| No | 4 | S | Indirect | see footnote |
| No | 4 | S | Indirect | see footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 376,247 | Indirect | see footnote |
| Common Stock | 6,245 | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $73.265 to $74.26. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $74.2753 to $74.50. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Michael J. Jandernoa Trust of which Mr. Jandernoa is the trustee.
- The price in column 4 is a weighted average. The prices actually received ranged from $73.1328 to $74.00. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Susan M. Jandernoa Trust of which Mrs. Jandernoa is the trustee.
Billionaire Hedge Funds
